HØREKLINIKKEN VALBY ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.7% 0.7% 0.7% 0.7% 0.7%  
Bankruptcy risk  17.3% 12.6% 18.0% 19.8% 19.6%  
Credit score (0-100)  9 17 7 5 6  
Credit rating  BB BB B B B  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  31.7 22.1 33.9 38.5 37.5  
EBITDA  -804 21.4 33.9 38.5 37.5  
EBIT  -804 21.4 33.9 38.5 37.5  
Pre-tax profit (PTP)  -826.3 21.6 23.6 23.7 13.5  
Net earnings  -826.3 21.6 23.6 23.7 13.5  
Pre-tax profit without non-rec. items  -826 21.6 23.6 23.7 13.5  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -550 -528 -504 -481 -467  
Interest-bearing liabilities  0.0 566 0.0 0.0 0.0  
Balance sheet total (assets)  44.5 44.0 7.3 7.1 7.5  

Net Debt  -0.7 566 -1.4 -0.9 -0.9  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  31.7 22.1 33.9 38.5 37.5  
Gross profit growth  -40.9% -30.4% 53.7% 13.6% -2.6%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  44 44 7 7 8  
Balance sheet change%  -94.9% -1.1% -83.5% -2.6% 6.7%  
Added value  -803.5 21.4 33.9 38.5 37.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 2.0 3.0 4.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -2,533.0% 97.1% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -110.0% 3.7% 6.3% 7.8% 7.9%  
ROI %  -580.9% 7.6% 12.1% 0.0% 0.0%  
ROE %  -514.7% 49.0% 92.1% 331.4% 184.3%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  -92.5% -92.3% -98.6% -98.6% -98.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.1% 2,641.5% -4.1% -2.3% -2.5%  
Gearing %  0.0% -107.2% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 3.7% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.1 0.1 0.0 0.0 0.0  
Current Ratio  0.1 0.1 0.0 0.0 0.0  
Cash and cash equivalent  0.7 0.0 1.4 0.9 0.9  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -549.7 -528.0 -504.5 -480.7 -467.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0